DCK and cervical carcinoma: Our results strongly suggest that in this model of gemcitabine resistance in cervical cancer, methylation at H3K9 could be the main mechanism for silencing the expression of hENT1 and dCK genes which paves the way for further testing the participation of this histone modification in other models of chemotherapy resistance.